Oramed Pharmaceuticals Inc (ORMP) — Cash Flow-to-Debt Ratio
Oramed Pharmaceuticals Inc (ORMP) has a Cash Flow-to-Debt Ratio of -0.10x as of March 2026, meaning its operating cash flow of $-2.92 Million could theoretically repay 0% of its total liabilities ($30.57 Million) in one year. Explore long-term investment intensity of Oramed Pharmaceuticals Inc to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Oramed Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Oramed Pharmaceuticals Inc across 22 annual periods. Also explore total assets of Oramed Pharmaceuticals Inc for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Oramed Pharmaceuticals Inc (2003–2025)
Year-by-year debt coverage analysis for Oramed Pharmaceuticals Inc. For market capitalisation and broader financial context, see ORMP market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.29x | $-9.14 Million | $31.12 Million | ▲ +65.3% |
| 2024 | -0.85x | $-8.41 Million | $9.93 Million | ▼ -374.4% |
| 2023 | -0.18x | $-10.29 Million | $57.66 Million | ▲ +93.5% |
| 2022 | -2.74x | $-28.70 Million | $10.49 Million | ▼ -48.4% |
| 2021 | -1.84x | $-21.18 Million | $11.48 Million | ▼ -74.3% |
| 2020 | -1.06x | $-12.44 Million | $11.75 Million | ▼ -24.9% |
| 2019 | -0.85x | $-12.94 Million | $15.27 Million | ▲ +5.8% |
| 2018 | -0.90x | $-14.66 Million | $16.29 Million | ▼ -200.6% |
| 2017 | -0.30x | $-5.83 Million | $19.47 Million | ▼ -207.0% |
| 2016 | 0.28x | $4.66 Million | $16.64 Million | ▲ +108.6% |
| 2015 | -3.24x | $-4.95 Million | $1.53 Million | ▲ +19.6% |
| 2014 | -4.03x | $-4.07 Million | $1.01 Million | ▲ +37.1% |
| 2013 | -6.41x | $-3.40 Million | $529.41K | ▼ -322.7% |
| 2012 | -1.52x | $-2.30 Million | $1.52 Million | ▲ +45.2% |
| 2011 | -2.77x | $-1.67 Million | $602.02K | ▼ -21.1% |
| 2010 | -2.29x | $-1.42 Million | $620.62K | ▲ +47.7% |
| 2009 | -4.37x | $-2.25 Million | $515.66K | ▼ -117.4% |
| 2008 | -2.01x | $-1.84 Million | $913.95K | ▼ -368.4% |
| 2007 | -0.43x | $-611.00K | $1.42 Million | ▲ +27.7% |
| 2006 | -0.59x | $-361.61K | $608.91K | ▲ +32.3% |
| 2005 | -0.88x | $-40.44K | $46.07K | ▲ +78.1% |
| 2003 | -4.00x | $-40.00K | $10.00K | — |